Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Biora Therapeutics, Inc. - Common Stock (NQ: BIOR ) 3.349 UNCHANGED Streaming Delayed Price Updated: 3:56 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Biora Therapeutics, Inc. - Common Stock < Previous 1 2 3 4 5 6 Next > 12 Health Care Stocks Moving In Tuesday's Intraday Session October 29, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session October 29, 2024 Via Benzinga Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules October 29, 2024 From Biora Therapeutics, Inc. Via GlobeNewswire Biora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting October 28, 2024 Expanded collaborations to support rapid testing in advanced animal models in Q4 2024 From Biora Therapeutics, Inc. Via GlobeNewswire Biora Therapeutics to Reveal 00-Size BioJet™ Device at the 14th Annual Partnership Opportunities in Drug Delivery Meeting October 14, 2024 From Biora Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's After-Market Session October 08, 2024 Via Benzinga Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics Symposium October 07, 2024 From Biora Therapeutics, Inc. Via GlobeNewswire Biora Therapeutics Announces Award-Winning Abstract to be Presented at American College of Gastroenterology Annual Scientific Meeting 2024 September 30, 2024 From Biora Therapeutics, Inc. Via GlobeNewswire Biora Therapeutics Achieves ISO 13485 Certification September 09, 2024 Underscoring the company’s commitment to quality and excellence From Biora Therapeutics, Inc. Via GlobeNewswire Biora Therapeutics Announces Positive Nasdaq Listing Decision August 28, 2024 Company granted extension to regain compliance with Nasdaq listing requirements From Biora Therapeutics, Inc. Via GlobeNewswire Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference August 26, 2024 From Biora Therapeutics, Inc. Via GlobeNewswire BIOR Stock Earnings: Biora Therapeutics Beats EPS for Q2 2024 August 12, 2024 BIOR stock results show that Biora Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results August 12, 2024 From Biora Therapeutics, Inc. Via GlobeNewswire Biora Therapeutics Announces Funding Agreement with Existing Investors August 12, 2024 $16 million multiple-draw facility to be used as a bridge to anticipated pharma partnership From Biora Therapeutics, Inc. Via GlobeNewswire Biora Therapeutics to Report Second Quarter 2024 Financial Results and Provide Corporate Update August 08, 2024 From Biora Therapeutics, Inc. Via GlobeNewswire Biora Therapeutics to Participate in Canaccord Genuity 44th Annual Growth Conference August 06, 2024 From Biora Therapeutics, Inc. Via GlobeNewswire Biora Therapeutics Announces Supplemental Data from Phase 1 Clinical Trial of BT-600 as Presented at KOL Event July 18, 2024 From Biora Therapeutics, Inc. Via GlobeNewswire Biora Therapeutics to Host Virtual KOL Event on NaviCap™ Targeted Oral Delivery Platform and Results from Phase 1 Clinical Trial of BT-600 on July 17, 2024 July 08, 2024 From Biora Therapeutics, Inc. Via GlobeNewswire Biora Therapeutics Announces Positive Clinical Trial Results for BT-600 July 01, 2024 From Biora Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Monday's After-Market Session June 17, 2024 Via Benzinga Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next Gen Peptide Formulation & Delivery Summit 2024 June 11, 2024 From Biora Therapeutics, Inc. Via GlobeNewswire Why NetEase Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session May 24, 2024 Via Benzinga Why Ross Stores Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket May 24, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session May 24, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session May 23, 2024 Via Benzinga Biora Therapeutics Presents Clinical Data on Device Function of the NaviCap™ Platform at Digestive Disease Week 2024 May 20, 2024 Four clinical device performance studies successfully demonstrate the NaviCap platform’s ability to deliver therapeutics directly to the colon under variable GI conditions and eating schedules From Biora Therapeutics, Inc. Via GlobeNewswire BIOR Stock Earnings: Biora Therapeutics Beats EPS for Q1 2024 May 15, 2024 BIOR stock results show that Biora Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Biora Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results May 15, 2024 From Biora Therapeutics, Inc. Via GlobeNewswire Biora Therapeutics to Report First Quarter 2024 Financial Results and Provide Corporate Update May 07, 2024 From Biora Therapeutics, Inc. Via GlobeNewswire Biora Therapeutics to Present Clinical Data on Device Function of the NaviCap™ Oral Delivery Platform at Digestive Disease Week 2024 May 06, 2024 From Biora Therapeutics, Inc. Via GlobeNewswire < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
